Sign in
4/A

Changes in Ownership

GT Biopharma, Inc. Filed Acc 0001181431-03-034752

Options or other derivatives

  • Director acquired 1,754 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WEBB TED FORD · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2003-12-04 Grant or award : show line 1 in the form Stock Option (right to buy) +1,754 $0.57 $1,000 31,754 D
Loading xslF345X02/rrd25093.xml…